Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Magrini

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Human Pathology|November 21, 1998
Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamilyM Paulli, E Berti, E Boveri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patientsM Lazzarino, E Orlandi, M Paulli, et al.
Leukemia & Lymphoma|May 7, 1998
Primary mediastinal B-cell lymphoma: update of its clinicopathologic featuresM Paulli, M Lazzarino, U Gianelli, et al.
The American Journal of Pathology|September 15, 1998
ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrumB Falini, B Bigerna, M Fizzotti, et al.
Pathologica|June 23, 2006
[The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics]M Paulli, T Artusi, C D Baroni, et al.
Nature Genetics|September 6, 2000
Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome ConsortiumM Seri, R Cusano, S Gangarossa, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Human Pathology|November 21, 1998
Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamilyM Paulli, E Berti, E Boveri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patientsM Lazzarino, E Orlandi, M Paulli, et al.
Leukemia & Lymphoma|May 7, 1998
Primary mediastinal B-cell lymphoma: update of its clinicopathologic featuresM Paulli, M Lazzarino, U Gianelli, et al.
The American Journal of Pathology|September 15, 1998
ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrumB Falini, B Bigerna, M Fizzotti, et al.
Pathologica|June 23, 2006
[The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics]M Paulli, T Artusi, C D Baroni, et al.
Nature Genetics|September 6, 2000
Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome ConsortiumM Seri, R Cusano, S Gangarossa, et al.
Pageof 9